The deal entails enterprise-wide standardisation across 37 clinical sites and approximately 400 practitioner licences nationwide. Approximately £77,000 in annual recurring subscription revenue, representing an initial deployment with expansion potential as the network grows.
LONDON, UK, June 30, 2026
Physitrack plc (Nasdaq First North: PTRK) today announced an agreement generating approximately £77,000 in annual recurring revenue, standardising digital rehabilitation across 37 clinical sites and approximately 400 practitioner licences for one of the UK's largest independent healthcare providers, with expansion potential as the network grows.
Highlights:
The customer, a nationwide independent operator of physiotherapy and rehabilitation services, previously used products within the Physitrack ecosystem and has now consolidated exclusively on Physitrack, covering exercise prescription, patient engagement, outcomes tracking, and a branded iOS, Android, and web application.
Henrik Molin, CEO and Founder of Physitrack plc, commented: "This deal shows our strategy in execution, creating a long-term expansion from an existing relationship. This in turn creates recurring, embedded revenue that leaves lasting value for our shareholders."